NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY SURGERY IN ADVANCED OVARIAN CANCER. MORBIDITY AND PROGRESSION FREE STUDY

Picture 2 (1)Heru Priyanto,Andrijono

Abstract
Objective. The aim of the study was to compare the morbidity and progression free of disease women with advanced ovarian cancer treated with neoadjuvant chemotherapy (NAC) followed by surgery with those treated conventionally with cytoreductive surgery followed by cytotoxic chemotherapy.

Continue reading “NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY SURGERY IN ADVANCED OVARIAN CANCER. MORBIDITY AND PROGRESSION FREE STUDY”

Endodermal Sinus Tumor

2-Ayah
Endodermal Sinus Tumor Role of Conservative Surgery and Chemotherapy. Update Review ~| Heru Priyanto |~

Introduction
Endodermal sinus tumor ( EST ) is second most common malignant ovarian germ cell tumor. The management of these tumor can be challenging, but a rational approach can be outline based on current data. Occurs in childhood, adolescence, and adult life (most <30 years), EST can be pure or a component of a mixed germ cell tumor and almost always a unilateral solid or solid and cystic tumor. (1-2 )
Continue reading “Endodermal Sinus Tumor”